Scott Gottlieb
CIK 1411359 · last filed 2026-10-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TEM price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
160 SECOND STREET
CAMBRIDGE, MA 02142
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UNH | Director | 921 | $398.24 | $366.8K | $0 | 7 | 2026-10-05 |
| TEM | Director | 40,749 | $84.60 | $3.45M | -$2.67M | 5 | 2026-05-26 |
| ILMN | Director | 14,795 | $221.29 | $3.27M | $84.6K | 14 | 2026-05-22 |
| PFE | Director | 10,000 | $29.57 | $295.6K | $325.8K | 13 | 2026-04-27 |
| CombiMatrix Corp (CBMX) Delisted | Director | 4,804 | — | — | $27.1K | 10 | 2016-05-10 |
| Molecular Insight Pharmaceuticals, Inc. (MIPI) Delisted | Director | 4,000 | — | — | $15.3K | 3 | 2010-05-17 |
Recent Filings · Page 3 of 6
54 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-17 | ILMN | Grant (A) | +2,622 | $0 | EDGAR |
| 2024-04-26 | PFE | Grant (A) | — | $0 | EDGAR |
| 2024-01-02 | ILMN | Grant (A) | +220 | $25.0K | EDGAR |
| 2023-12-19 | PFE | Buy (P) | +3,000 | $79.4K | EDGAR |
| 2023-10-03 | ILMN | Grant (A) | +142 | $23.7K | EDGAR |
| 2023-07-03 | ILMN | Grant (A) | +103 | $21.2K | EDGAR |
| 2023-05-31 | ILMN | Grant (A) | +1,532 | $0 | EDGAR |
| 2023-05-09 | PFE | Buy (P) | +2,000 | $77.0K | EDGAR |
| 2023-04-28 | PFE | Grant (A) | — | $0 | EDGAR |
| 2023-04-04 | ILMN | Grant (A) | +100 | $21.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.